心血管疾患患者の栄養状態評価ツール
Izabela Jarosz1, Kamil Gorecki1, Grzegorz Kalisz2
1Department of Clinical Dietetics, Medical University of Lublin, ul. Chodzki 7, 20-093 Lublin, Poland.
Nutrients
|August 28, 2025
まとめ
栄養不良は心臓血管疾患 (CVD) の患者でよく見られ,結果が悪化します. このレビューは,栄養状態の評価における課題を強調し,心血管疾患の集団におけるよりよい検出と管理のために,多式アプローチを推奨しています.
科学分野:
- 心臓病科
- 栄養学
- 医療診断
背景:
- 栄養不良は心臓血管疾患 (CVD) の患者で広く知られていません.
- 長期の入院,再入院,死亡率などの有害な結果と関連しています.
- ボディマス指数 (BMI) のような従来の指標は,体液保持や肥満などの要因により,心血管疾患における栄養失調の検出にはしばしば不十分です.
研究 の 目的:
- 心血管疾患 (CVD) 集団における現在の栄養評価ツールを批判的に検討する.
- CVDの文脈で様々なスクリーニングと診断ツールの適用性と限界を議論する.
- CVD患者の栄養状態の評価のための最適化されたアプローチを提案する.
主な方法:
- 確立された栄養スクリーニングツール (NRS 2002,MNA,MUST,SGA,CONUT) のレビュー
- 栄養不良に関するグローバル・リーダーシップ・イニシアチブ (GLIM) の基準を含む診断枠組みの検討
- 生物電気阻力分析 (BIA) や相角度 (PA) などの体組成評価方法の評価
主要な成果:
- 既存の栄養評価ツールには,CVDの診断性能と適用性が異なっています.
- CVD特有の病理生理学的特徴 (炎症,液体の不均衡,薬剤) は,ツールの精度に影響します.
- GLIM基準は標準化されたアプローチですが,心臓病学ではさらなる検証が必要です.
結論:
- 初期スクリーニングと確認評価を含むマルチモダルの戦略は,CVD患者のために推奨されます.
- 筋肉の質量と細胞の整合性の客観的な測定と並行してGLIM基準を使用することが提案されています.
- 臨床医は,栄養評価を解釈する際に,ツール特有の制限とCVDに関連する課題を考慮する必要があります.
関連する概念動画
01:23Assessment of the Cardiovascular System I: Subjective Data
467
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
467
01:29Assessment of the Cardiovascular System II: Inspection
404
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
404
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
01:27Assessment of the Cardiovascular System III: Palpation
492
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
492
01:29Cardiovascular System Abnormal Findings I: Inspection and Palpation
515
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Abnormal findings observed during an inspection
515